{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:21:35Z","timestamp":1791105695585,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.neuropharm.2008.12.009","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T04:25:42Z","timestamp":1230697542000},"page":"761-767","source":"Crossref","is-referenced-by-count":26,"title":["Alterations of N\/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats"],"prefix":"10.1016","volume":"56","author":[{"given":"Manuela","family":"Di Benedetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"D'Addario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanzio","family":"Candeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Romualdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.12.009_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704264","article-title":"Inhibitory action of nociceptin\/orphanin FQ on functionally different thalamic neurons in urethane-anesthetized rats","volume":"134","author":"Albrecht","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00441-004-0921-7","article-title":"Synucleins and their relationship to Parkinson's disease","volume":"318","author":"von Bohlen Und Halbach","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1471-4159.2006.03902.x","article-title":"Differential protection against MPTP or methamphetamine toxicity in DA neurons by deletion of ppN\/OFQ expression","volume":"98","author":"Brown","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bjp.0704706","article-title":"[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin\/orphanin FQ receptor","volume":"136","author":"Cal\u00f2","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.jcbfm.9600364","article-title":"Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism","volume":"27","author":"Emborg","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0896-6273(91)90077-D","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1034\/j.1399-0004.1998.5440401.x","article-title":"Genetics of Parkinson's disease","volume":"54","author":"Gasser","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/brain\/awh029","article-title":"The subthalamic nucleus in the context of movement disorders","volume":"127","author":"Hamani","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0028-3908(84)90170-9","article-title":"Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice","volume":"23","author":"Heikkila","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib15","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm990517p","article-title":"Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397)","volume":"42","author":"Kawamoto","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J.\u00a0Med."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J.\u00a0Med."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib18","first-page":"309","article-title":"Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","author":"Langston","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.gt.3302520","article-title":"Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models","volume":"12","author":"Lee","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1074549","article-title":"Subthalamic GAD gene therapy in a Parkinson's disease rat model","volume":"298","author":"Luo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00001756-200207020-00013","article-title":"Rat ventral midbrain dopamine neurons express the orphanin FQ\/nociceptin receptor ORL-1","volume":"13","author":"Maidment","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.20780","article-title":"Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats","volume":"21","author":"Marin","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4522(02)00050-7","article-title":"Nociceptin\/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat","volume":"112","author":"Marti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1471-4159.2004.02843.x","article-title":"Blockade of nociceptin\/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release","volume":"91","author":"Marti","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib26","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1523\/JNEUROSCI.0987-04.2004","article-title":"Blockade of nociceptin\/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior","volume":"24","author":"Marti","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1523\/JNEUROSCI.4346-06.2007","article-title":"The nociceptin\/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway","volume":"27","author":"Marti","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1469-7793.2001.0701e.x","article-title":"Control of glutamate and GABA release by nociceptin\/orphanin FQ in the rat lateral amygdala","volume":"532","author":"Meis","year":"2001","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(98)03453-9","article-title":"Parkinson's disease, pesticides, and glutathione transferase polymorphisms","volume":"352","author":"Menegon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z","article-title":"Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding","volume":"412","author":"Neal","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.10154","article-title":"Nociceptin\/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems","volume":"444","author":"Norton","year":"2002","journal-title":"J. Comp. Neurol."},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2008.12.009_bib33","first-page":"S7","article-title":"Pathophysiologic basis of surgery for Parkinson's disease","volume":"55","author":"Obeso","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2008.12.009_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","article-title":"Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2003.tb07477.x","article-title":"Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder","volume":"991","author":"Wichmann","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib39","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1523\/JNEUROSCI.1528-04.2004","article-title":"GABA, not glutamate, controls the activity of substantia nigra reticulata neurons in awake, unrestrained rats","volume":"24","author":"Windels","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.12.009_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bjp.0704806","article-title":"Actions of orphanin FQ\/nociceptin on rat ventral tegmental neurons in vitro","volume":"136","author":"Zheng","year":"2002","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808005327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808005327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T03:31:13Z","timestamp":1545535873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808005327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0028390808005327"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.12.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}